» Authors » A Peer

A Peer

Explore the profile of A Peer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 45
Citations 364
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Thabit S, OConnor M, Parker W, Mashishi T, Moodley K, Peer A, et al.
S Afr Med J . 2024 Nov; 114(8):e1246. PMID: 39508198
Background: Pathology of the hand causes functional impairment, with downstream effects for patient occupation, and consequently presents a socioeconomic burden. Investigation of the epidemiology of hand pathology in KwaZulu-Natal (KZN)...
2.
Abu-Shawareb H, Acree R, Adams P, Adams J, Addis B, Aden R, et al.
Phys Rev Lett . 2024 Feb; 132(6):065102. PMID: 38394591
On December 5, 2022, an indirect drive fusion implosion on the National Ignition Facility (NIF) achieved a target gain G_{target} of 1.5. This is the first laboratory demonstration of exceeding...
3.
Abu-Shawareb H, Acree R, Adams P, Adams J, Addis B, Aden R, et al.
Phys Rev Lett . 2022 Aug; 129(7):075001. PMID: 36018710
For more than half a century, researchers around the world have been engaged in attempts to achieve fusion ignition as a proof of principle of various fusion concepts. Following the...
4.
Sternberg C, Saad F, Graff J, Peer A, Vaishampayan U, Leung E, et al.
Ann Oncol . 2020 Jan; 31(2):257-265. PMID: 31959342
Background: Radium-223 prolongs overall survival and delays symptomatic skeletal events (SSEs) in patients with metastatic castration-resistant prostate cancer (mCRPC) and bone metastases. The approved radium-223 regimen is 55 kBq/kg every...
5.
Sartor O, Heinrich D, Mariados N, Mendez Vidal M, Keizman D, Thellenberg Karlsson C, et al.
Ann Oncol . 2017 Sep; 28(10):2464-2471. PMID: 28961839
Background: Six radium-223 injections at 4-week intervals is indicated for patients with castration-resistant prostate cancer and symptomatic bone metastases. However, patients usually develop disease progression after initial treatment. This prospective...
6.
Keizman D, Fosboel M, Reichegger H, Peer A, Rosenbaum E, Desax M, et al.
Prostate Cancer Prostatic Dis . 2017 Mar; 20(3):289-293. PMID: 28244493
Background: The imaging response to radium-223 therapy is at present poorly described. We aimed to describe the imaging response to radium-223 treatment. Methods: We retrospectively evaluated the computed tomography (CT)...
7.
Peer A, Khamaisi M
J Dent Res . 2014 Dec; 94(2):252-60. PMID: 25477311
Medication-related osteonecrosis of the jaw (MRONJ) is a severe devastating complication for which the exact pathogenesis is not completely understood. Multiple systemic and local factors may contribute to the development...
8.
Kapeller C, Hintermuller C, Abu-Alqumsan M, Pruckl R, Peer A, Guger C
Annu Int Conf IEEE Eng Med Biol Soc . 2013 Oct; 2013:5254-7. PMID: 24110921
A brain-computer interface (BCI) translates brain activity into commands to control devices or software. Common approaches are based on visual evoked potentials (VEP), extracted from the electroencephalogram (EEG) during visual...
9.
Kabbani T, GOLDBERG A, Kelly C, Pallav K, Tariq S, Peer A, et al.
Aliment Pharmacol Ther . 2012 Feb; 35(6):723-9. PMID: 22316503
Background: Coeliac disease is increasingly diagnosed and weight changes are common after adoption of a gluten-free diet (GFD), however data on body mass index (BMI) changes are limited. Aim: To...
10.
Pallav K, Leffler D, Tariq S, Kabbani T, Hansen J, Peer A, et al.
Aliment Pharmacol Ther . 2011 Dec; 35(3):380-90. PMID: 22145590
Background: Duodenal villous atrophy (DVA) is a key diagnostic finding in coeliac disease (CD). However, the differential diagnosis for this finding is broad. Aim: To identify conditions causing noncoeliac enteropathy...